Inactive

The Centers for Disease Control and Prevention intends to award a sole source FIRM-FIXED-PRICE price purchase order to the Genscript USA, INC for supply knock-in clones of the T cell receptor excision... The Centers for Disease Control and Prevention intends to award a sole source FIRM-FIXED-PRICE price purchase order to the Genscript USA, INC for supply knock-in clones of the T cell receptor excision circle (TREC) DNA sequence inserted into two (2) B-lympoblast cell lines. Genscript USA INC. is the sole manufacturer of supply knock-in clones of the T cell receptor excision circle (TREC) DNA sequence inserted into two (2) B-lympoblast cell lines that the CDC is currently using. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) and 41 USC 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within seven (7) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at QYA0@CDC.GOV by 12:00 pm on May 05, 2021.